AIP
ALT icon

Ameritas Investment Partners’s Altimmune ALT Stock Holding History

Ameritas Investment Partners’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.9K Buy
10,680
+3,725
+54% +$15.8K ﹤0.01% 2342
2025
Q4 		$25.1K Hold
6,955
– – ﹤0.01% 2521
2025
Q3 		$26.2K Hold
6,955
– – ﹤0.01% 2542
2025
Q2 		$26.9K Hold
6,955
– – ﹤0.01% 2526
2025
Q1 		$34.8K Hold
6,955
– – ﹤0.01% 2300
2024
Q4 		$50.1K Hold
6,955
– – ﹤0.01% 2182
2024
Q3 		$42.7K Buy
6,955
+1,485
+27% +$10.1K ﹤0.01% 2281
2024
Q2 		$36.4K Hold
5,470
– – ﹤0.01% 2311
2024
Q1 		$55.7K Hold
5,470
– – ﹤0.01% 2086
2023
Q4 		$61.5K Buy
5,470
+1,388
+34% +$5.79K ﹤0.01% 2042
2023
Q3 		$10.6K Hold
4,082
– – ﹤0.01% 2823
2023
Q2 		$14.4K Buy
+4,082
New +$18.3K ﹤0.01% 2734
2022
Q2 		– Sell
-3,098
Closed -$19K – 3063
2022
Q1 		$19K Hold
3,098
– – ﹤0.01% 2576
2021
Q4 		$28K Hold
3,098
– – ﹤0.01% 2473
2021
Q3 		$35K Buy
3,098
+550
+22% +$6.69K ﹤0.01% 2373
2021
Q2 		$25K Buy
+2,548
New +$34.8K ﹤0.01% 2611
2017
Q2 		– Sell
-16
Closed -$4K – 2994
2017
Q1 		$4K Buy
+16
New +$8.56K ﹤0.01% 2867

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Ameritas Investment Partners's ALT Position: Q1 2026 in Review

Ameritas Investment Partners increased its Altimmune (ALT) stake by 54% in Q1 2026, buying an estimated $15.8K and bringing the position to 10,680 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2342.

Ameritas Investment Partners first reported a position in ALT in Q1 2017 and has held it in 17 quarters since. The position peaked at $61.5K in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Ameritas Investment Partners held 10,680 shares of Altimmune worth $32.9K as of Q1 2026.
  • Ameritas Investment Partners bought 3,725 Altimmune shares in Q1 2026, an estimated $15.8K.
  • Altimmune made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2342 holding.
  • Ameritas Investment Partners first reported a position in Altimmune in Q1 2017 and has held it in 17 quarters since.
  • Ameritas Investment Partners's Altimmune position peaked at $61.5K in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.